Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 37.70
0.00 (0.00%)
Aug 18, 2026, 1:30 PM CST
TPEX:4139 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,083 | 1,093 | 1,130 | 1,218 | 1,059 | 959.45 |
Revenue Growth | -4.45% | -3.34% | -7.21% | 15.05% | 10.35% | 5.41% |
Gross Profit Gross Profit Growth | 124.16 | 138.77 | 150.47 | 171.77 | 160.7 | 173.16 |
Operating Income Operating Income Growth | -39.18 | -26.17 | 14.99 | 24.79 | 37.99 | 45.64 |
Net Income Net Income Growth | -79.04 | -67.08 | 10.28 | -42.53 | -30.9 | 38.54 |
Earnings Per Share EPS Growth | -1.80 | -1.55 | 0.24 | -1.00 | -0.73 | 0.90 |
EPS Growth | - | - | - | - | - | -50.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Singapore and Malaysia Region Chain Traditional Chinese Medicine Singapore and Malaysia Region Chain Traditional Chinese Medicine Growth | 758.95 | 753.34 | 698.54 | 626.09 | 473.85 | 392.42 |
Medical Management Training and Education in Singapore Medical Management Training and Education in Singapore Growth | 84.02 | 82.17 | 80.76 | 69.36 | 49.19 | 47.09 |
Chain Community Health Care in Tianjin Chain Community Health Care in Tianjin Growth | 237.7 | 255.45 | 342.47 | 518 | 521.3 | 516.16 |
Adjustments and Eliminations Adjustments and Eliminations Growth | -51.74 | -50.78 | -41.84 | -45.3 | -42.54 | -38.48 |
Other Other Growth | 54.03 | 52.33 | 50.34 | 49.97 | 56.95 | 42.26 |
Total Total Growth | 1,083 | 1,093 | 1,130 | 1,218 | 1,059 | 959.45 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 89.77 | 126.19 | 73.54 | 91.72 | 91.79 | 85.24 |
Total Debt Total Debt Growth | 632.7 | 686.85 | 710.35 | 881.32 | 828.58 | 651.11 |
Net Cash (Debt) Net Cash Growth | -542.93 | -560.66 | -636.81 | -789.6 | -736.79 | -565.86 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -12.38 | -12.96 | -14.97 | -18.56 | -17.32 | -13.29 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 239.41 | 238.9 | 340.13 | 199.59 | 189.88 | 232.07 |
Capital Expenditures CapEx Growth | -24.03 | -25.09 | -26.65 | -36.63 | -141.84 | -40.31 |
Free Cash Flow Free Cash Flow Growth | 215.38 | 213.81 | 313.48 | 162.95 | 48.04 | 191.77 |
Free Cash Flow Growth | -26.51% | -31.80% | 92.37% | 239.22% | -74.95% | -32.51% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 11.46% | 12.70% | 13.31% | 14.10% | 15.18% | 18.05% |
Operating Margin | -3.62% | -2.40% | 1.33% | 2.04% | 3.59% | 4.76% |
Pretax Margin | -7.47% | -6.21% | 0.95% | -2.33% | -2.85% | 5.90% |
Profit Margin | -7.30% | -6.14% | 0.91% | -3.49% | -2.92% | 4.02% |
FCF Margin | 19.89% | 19.57% | 27.73% | 13.38% | 4.54% | 19.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 133.67 | - | - | 47.91 |
Forward PE | - | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 |
P/FCF Ratio | 7.88 | 5.17 | 4.38 | 9.09 | 37.47 | 9.63 |
PS Ratio | 1.57 | 1.01 | 1.22 | 1.22 | 1.70 | 1.93 |